Navigation Links
Generation in Medical Technology
... of hepatitis C (HCV). PSI-7851 is a second generation nucleotide polymerase inhibitor of HCV.
... and safety data with PSI-7851, our second generation nucleotide analog," said Michelle Berrey, MD, ... 15-fold more potent than Pharmasset's first generation nucleoside polymerase inhibitor, RG7128 (formerly ...
... today the first complete prototype of their next generation LifeShirt for the remote monitoring of patients' ... realization of telemedicine. The next generation LifeShirt incorporates cutting-edge sensor ... intent is to address these needs with the next generation LifeShirt and help make the full promise of RPM a ...
... Forum's commitment to developing a new generation of tools for physicians to learn from peer ... a complementary, accelerated path to knowledge generation and dissemination. "The end goal of this ... ( www.ICSciences.com ). The EVF NGHI (next generation health Internet) community comes together to ...
... important new technology is that it allows the generation of both knock-out rat models, in which the effect of gene deletion is studied, as well as the generation of knock-in models, which involves the insertion ... "This remarkable breakthrough will enable the generation of transgenic rat models for drug discovery in a ...
... a first-in-human micro-dosing study of our second generation NNRTI, RDEA427, and selected it as a ... a first-in-human micro-dosing study of our second generation MEK inhibitor, RDEA436, and selected it as a ... favorable resistance profiles for our next generation NNRTI family of compounds against HIV at the ...
... nucleases (ZFNs(TM)) in a new approach for rapid generation of "knock-out" cell lines, important tools in ... advance in the specificity and efficiency of the generation of cell lines in which an individual gene ... vice president of research. "The generation of knockouts in basic research and industrial ...
... to advance our development of picoplatin, a new generation chemotherapy agent with the potential to become a ... . About Picoplatin Picoplatin is a new generation platinum chemotherapy agent with the potential to ... lead platform product candidate, is a new generation platinum therapy with an improved safety profile. ...
... in stem cells potentially enabling the efficient generation of stem cell lines for use as models of human ... for drug testing. In addition to its use in the generation of valuable research reagents, the technology has ... has revolutionized biology and enabled the generation of mouse cell-lines and transgenic mouse models ...
... announced results from a Phase 1 cardiac safety study of picoplatin, a new generation platinum-based chemotherapy agent and the Company's lead product ... later this year. About Picoplatin Picoplatin is a new generation platinum-based chemotherapy agent that is in clinical development for ...
... be developed for rheumatoid arthritis as well." Thiarabine is a next generation nucleoside analogue that Access has licensed from Southern Research. It ... factor and is targeted to breast cancer; and Thiarabine , a new generation nucleoside analog which has demonstrated both pre-clinical and clinical ...
... with Genentech, Inc., a wholly-owned member of the Roche Group, for the generation of cell lines with novel characteristics for pharmaceutical protein ... obviates the need for selection markers, thereby enabling the rapid generation of cell lines in which multiple genes have been knocked out. Our proven ...
... Second generation Oxazolidinone Demonstrates Safety and Efficacy with Once-Daily, 200 ... pathogens. The company's lead drug candidate, torezolid, is a second generation oral and IV oxazolidinone antibiotic with potent activity against ...
... development programs include: SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine Valortim(R) - ... RypVax(TM) - a recombinant dual antigen vaccine for plague A third generation rPA anthrax vaccine. For more information about ...
... Mass., May 15 /PRNewswire/ -- BioVex Inc, a company developing next generation biologics for the treatment and prevention of cancer and infectious ... recently commenced a Phase III study in metastatic melanoma following the generation of an unprecedented number of durable complete remissions in a Phase II ...
... development programs include: SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine Third generation rPA anthrax vaccine Valortim(R) - a fully human monoclonal ...
... rates during DuraHeart support were acceptable in comparison to first generation pulsatile and second generation axial flow LVADs. The event rate of bleeding requiring surgery (0.22 per ...
... development programs include: SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine Valortim(R) - ... RypVax(TM) - a recombinant dual antigen vaccine for plague A third generation rPA anthrax vaccine. For more information about ...
... changes in certain cells. Continued advances and cost efficiencies of next generation DNA sequencing technologies are enabling this more precise and detailed ... in cancer. The team concluded that transcriptome sequencing with next generation sequencing technologies such as the 454 Life Sciences platform is very ...
... 180 Patient Trial of 2nd generation Oxazolidinone Enrolls in Four Months SAN DIEGO, Jan. 26 /PRNewswire/ ... pathogens. The company's lead drug candidate, torezolid, is a second generation oral and IV oxazolidinone antibiotic with potent activity against ...
... for Proposal issued in 2007 with the intent to procure an MVA-based, third generation smallpox vaccine, Public Works and Government Services Canada, on behalf ... 25 % of the population. IMVAMUNE(R), Bavarian Nordic's new, third generation smallpox vaccine, offers a number of unique advantages compared to the old ...
... the pathway for the abnormal heart rhythm. The new study involves second generation software (Gen II) that uses a catheter believed to result in the formation ... temperature at the catheter's tip, overheating may occur, resulting in the generation of a less effective lesion. "While many studies involve less complex ...
... lead product development programs include: -- SparVax(TM) -- a second generation recombinant protective antigen (rPA) anthrax vaccine -- Third generation rPA anthrax vaccine -- Valortim(R) -- a fully human monoclonal antibody ...
... Libraries Program (MLP) is a full-scale production program emphasizing the generation of high quality probes and biological-chemical data for high-value ... abilities that will enable screening of diverse types of assays and generation of chemical probes to address a wide range of biological opportunities. ...
... today the first complete prototype of their next generation LifeShirt for the remote monitoring of patients' ... realization of telemedicine. The next generation LifeShirt incorporates cutting-edge sensor ... intent is to address these needs with the next generation LifeShirt and help make the full promise of RPM a ...
... Forum's commitment to developing a new generation of tools for physicians to learn from peer ... a complementary, accelerated path to knowledge generation and dissemination. "The end goal of this ... ( www.ICSciences.com ). The EVF NGHI (next generation health Internet) community comes together to ...
PharmAthene Submits SparVax(TM) Regulatory Strategy to FDA
... plans for licensure of SparVax(TM), a next generation recombinant protective antigen anthrax vaccine. ... to develop and procure 25 million doses of a next generation rPA anthrax vaccine for the country's civilian ... the advanced development and procurement of next generation rPA anthrax vaccines." About SparVax(TM) ...Pharmasset Initiates First Time in Human Study of PSI-7851 for the Treatment of Hepatitis C (HCV)
... in healthy volunteers with PSI-7851, a second generation nucleotide analog polymerase inhibitor of ... Pharmasset. PSI-7851 is a wholly owned, second generation nucleotide analog that was discovered by ... than the active metabolite of Pharmasset's first generation nucleoside polymerase inhibitor, R7128. In vitro ...Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives
... our technology platform, which is unique in its generation of novel, highly differentiated therapies and ... establishing the utility of ZFNs in the generation of transgenic animals and the potential ... ZFN technology as a new approach for rapid generation of "knock-out" cell lines (Santiago et al., 2008, ...... important new technology is that it allows the generation of both knock-out rat models, in which the effect of gene deletion is studied, as well as the generation of knock-in models, which involves the insertion ... "This remarkable breakthrough will enable the generation of transgenic rat models for drug discovery in a ...
... a first-in-human micro-dosing study of our second generation NNRTI, RDEA427, and selected it as a ... a first-in-human micro-dosing study of our second generation MEK inhibitor, RDEA436, and selected it as a ... favorable resistance profiles for our next generation NNRTI family of compounds against HIV at the ...
... nucleases (ZFNs(TM)) in a new approach for rapid generation of "knock-out" cell lines, important tools in ... advance in the specificity and efficiency of the generation of cell lines in which an individual gene ... vice president of research. "The generation of knockouts in basic research and industrial ...
... to advance our development of picoplatin, a new generation chemotherapy agent with the potential to become a ... . About Picoplatin Picoplatin is a new generation platinum chemotherapy agent with the potential to ... lead platform product candidate, is a new generation platinum therapy with an improved safety profile. ...
... in stem cells potentially enabling the efficient generation of stem cell lines for use as models of human ... for drug testing. In addition to its use in the generation of valuable research reagents, the technology has ... has revolutionized biology and enabled the generation of mouse cell-lines and transgenic mouse models ...
Researchers Create First Targeted Knockout Rats Using Zinc Finger Nuclease Technology
... modified animal models of human disease. ZFN technology will make the generation of such animals faster and will create new opportunities in species other ... transgenic rats using DNA or lentiviral vector microinjection. The generation of transgenic rats also is open to the scientific community through an ...... announced results from a Phase 1 cardiac safety study of picoplatin, a new generation platinum-based chemotherapy agent and the Company's lead product ... later this year. About Picoplatin Picoplatin is a new generation platinum-based chemotherapy agent that is in clinical development for ...
... be developed for rheumatoid arthritis as well." Thiarabine is a next generation nucleoside analogue that Access has licensed from Southern Research. It ... factor and is targeted to breast cancer; and Thiarabine , a new generation nucleoside analog which has demonstrated both pre-clinical and clinical ...
... with Genentech, Inc., a wholly-owned member of the Roche Group, for the generation of cell lines with novel characteristics for pharmaceutical protein ... obviates the need for selection markers, thereby enabling the rapid generation of cell lines in which multiple genes have been knocked out. Our proven ...
... Second generation Oxazolidinone Demonstrates Safety and Efficacy with Once-Daily, 200 ... pathogens. The company's lead drug candidate, torezolid, is a second generation oral and IV oxazolidinone antibiotic with potent activity against ...
Access Pharmaceuticals Announces Publication of Thiarabine Combination Data
... for download from the journal's website. "Thiarabine is a next generation nucleoside analogue, licensed by Access from Southern Research Institute ... factor and is targeted to breast cancer. Thiarabine is a new generation nucleoside analog which has demonstrated both pre-clinical and clinical ...... development programs include: SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine Valortim(R) - ... RypVax(TM) - a recombinant dual antigen vaccine for plague A third generation rPA anthrax vaccine. For more information about ...
First Jatropha Genome Completed by Synthetic Genomics Inc. and Asiatic Centre for Genome Technology
... it can be grown on marginal, non-food producing lands; has a very short generation time; can be productive for 30 to 40 years; and its seed oil and biomass ... of the genome, using both traditional Sanger sequencing and next generation sequencing, has revealed that the jatropha genome is approximately 400 ...... Mass., May 15 /PRNewswire/ -- BioVex Inc, a company developing next generation biologics for the treatment and prevention of cancer and infectious ... recently commenced a Phase III study in metastatic melanoma following the generation of an unprecedented number of durable complete remissions in a Phase II ...
... development programs include: SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine Third generation rPA anthrax vaccine Valortim(R) - a fully human monoclonal ...
Facet Solutions, Inc. Expands U.S. Pivotal Study With Next Generation Implant System
... Study for the treatment of lumbar spinal stenosis utilizes the second generation design technology from Facet Solutions, Inc. This technology enables the ... stability to the lumbar spine. Average implantation times with the second generation design are equivalent to implantation times for standard postero-lateral ...Pharmasset Voluntarily Halts Clinical Studies with Clevudine in Hepatitis B Infected Patients
... trial at the upcoming EASL meeting. Pharmasset's unpartnered second generation HCV nucleoside, PSI-7851, is progressing well in a phase I trial and we ... has completed a Phase 2 clinical trial. PSI-7851, an unpartnered second generation HCV nucleotide analogue recently entered phase 1 studies. Pegasys(R) ...AACR Data Highlights InNexus Preclinical Antibody Candidate
... ), a drug development company commercializing the next generation of monoclonal antibodies based on its technology, Dynamic Cross Linking ... InNexus is a drug development company commercializing the next generation of monoclonal antibodies based on its DXL technology, which improves the ...... rates during DuraHeart support were acceptable in comparison to first generation pulsatile and second generation axial flow LVADs. The event rate of bleeding requiring surgery (0.22 per ...
... development programs include: SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine Valortim(R) - ... RypVax(TM) - a recombinant dual antigen vaccine for plague A third generation rPA anthrax vaccine. For more information about ...
DSM Obtains Exclusive World-Wide License for Innovative Drug Delivery Technology
... platform, this will open up a broad range of opportunities for next generation drug delivery. DSM's activities in this field are a perfect illustration ... technology for the delivery of biologics and drugs is based on a next generation set of polymers exclusively licensed from Cornell University . Generated ...... changes in certain cells. Continued advances and cost efficiencies of next generation DNA sequencing technologies are enabling this more precise and detailed ... in cancer. The team concluded that transcriptome sequencing with next generation sequencing technologies such as the 454 Life Sciences platform is very ...
... 180 Patient Trial of 2nd generation Oxazolidinone Enrolls in Four Months SAN DIEGO, Jan. 26 /PRNewswire/ ... pathogens. The company's lead drug candidate, torezolid, is a second generation oral and IV oxazolidinone antibiotic with potent activity against ...
Gene Therapy Corrects Sickle Cell Disease in Laboratory Study
... altered blood-forming cells from the original treated mice into a second generation of sickle cell mice to show that the gamma-globin gene had incorporated ... blood-forming cells. Five months after that transplantation, the second generation of mice also showed production of fetal hemoglobin and correction of their ...... for Proposal issued in 2007 with the intent to procure an MVA-based, third generation smallpox vaccine, Public Works and Government Services Canada, on behalf ... 25 % of the population. IMVAMUNE(R), Bavarian Nordic's new, third generation smallpox vaccine, offers a number of unique advantages compared to the old ...
PharmAthene Initiates Phase I Clinical Trial of Nerve Agent Bioscavenger Protexia(R)
... lead product development programs include: -- SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine -- Third generation rPA anthrax vaccine -- Valortim(R) - a fully human monoclonal antibody ...... the pathway for the abnormal heart rhythm. The new study involves second generation software (Gen II) that uses a catheter believed to result in the formation ... temperature at the catheter's tip, overheating may occur, resulting in the generation of a less effective lesion. "While many studies involve less complex ...
... lead product development programs include: -- SparVax(TM) -- a second generation recombinant protective antigen (rPA) anthrax vaccine -- Third generation rPA anthrax vaccine -- Valortim(R) -- a fully human monoclonal antibody ...
... Libraries Program (MLP) is a full-scale production program emphasizing the generation of high quality probes and biological-chemical data for high-value ... abilities that will enable screening of diverse types of assays and generation of chemical probes to address a wide range of biological opportunities. ...
febit and TGen Collaborate to Study New DNA Capture Method
... conversation on the future direction of genomic research centers on next generation sequencing," said Matthew Huentelman, Ph.D., TGen associate investigator ... for TGen researchers to make a difference in research utilizing next generation sequencing." TGen has been a user of the Geniom One device for the ...First DuraHeart(TM) Left Ventricular Assist System Implanted in the U.S. Pivotal Trial
... readily available for the increasing need of heart failure patients. Third generation systems are anticipated to demonstrate improved outcomes and long term reliability. DuraHeart is the most advanced third generation centrifugal pump by virtue of the magnetically levitated impeller, ...New CyberKnife Technologies Demonstrate Dramatic Reduction in Treatment Times
... First Patients Treated Using Next generation CyberKnife System at Oklahoma CyberKnife Center ... Oklahoma CyberKnife, LLC purchased its CyberKnife System with all the next generation upgrades included, those same upgrades were made available to existing ...Aegera Initiates a Fifth Phase 1 and 2 Clinical Trial for AEG35156
... in a fifth phase 1 and 2 clinical oncology study of AEG35156, a second generation antisense therapeutic targeting XIAP, a key member of the Inhibitor of ... disable their normal response to apoptotic triggers. AEG35156, a second generation antisense which targets XIAP, is designed to lower the apoptotic threshold ...Start of Phase I Study for Intranasal Pandemic Influenza Vaccine deltaFLU
... its intranasal vaccine deltaFLU against pandemic influenza. This novel generation of a live-attenuated vaccine based on the deletion of the NS1 gene has ... has optimized the method of reverse genetics, which permits the generation of a vaccine against any potential influenza virus within a very short ...Other ContentsOther TagsOther Tags
(Date:5/20/2013)... compound abundant in the Mediterranean diet takes away cancer ... a very specific step in gene regulation, this compound ... as scheduled. , One way that cancer cells thrive ... to die on a regular cycle that is subject ... Ohio State University researchers, found that a compound in ...
(Date:5/20/2013)... New Geology articles posted online ... cover a wide swath of geoscience subdisciplines, including ... and paleobotany. Locations studied include Siberia; the Sumatran ... Apuane, Italy; Ukraine; Mars; and the Southeastern U.S. ... Rubies, jadeite, and plate tectonics;, 2. The clear ...
(Date:5/18/2013)... AGA Research Foundation is honored to announce the first ... Cancer, which will support Andrew D. Rhim, MD, from ... Pennsylvania, Philadelphia, as he furthers his research on the ... progression. , "The AGA Research Foundation is humbled to ... and AGA Legacy Society members," said Nicholas F. LaRusso, ...
Breaking Biology News(10 mins):The compound in the Mediterranean diet that makes cancer cells 'mortal' 2The compound in the Mediterranean diet that makes cancer cells 'mortal' 3New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 2New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 3New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 4New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 5New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 6New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 7New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 8New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 9New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 10New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 11AGA Research Foundation grant furthers digestive cancer research 2(Date:5/21/2013)... agency for scientific and technological research So Paulo Research ... announced an investment estimated in US$ 680 million to ... a period of up to eleven years, subject to ... , Funding for the 17 RIDCs will come from ... support personnel, and infrastructure). Host institutions will participate in ...
(Date:5/21/2013)... York, New York (PRWEB) May 21, 2013 ... Vinci surgery robot lawsuit is nearing its conclusion ... According to Bloomberg.com, during closing statements yesterday, an attorney ... dealership, alleging the company wanted to tie sales and ... do all the training to keep control of surgeons, ...
(Date:5/21/2013)... Today, Zane Benefits, Inc. published a ... accounts. Zane Benefits, which provides comprehensive and flexible alternatives ... in defined contribution and http://HRA ... to Zane Benefits’ website, the Affordable Care Act (known ... in 2010 and impacts many areas of health care ...
(Date:5/21/2013)... Two executives from human resources and ... which strategies can be most effective to better manage ... members who are taking them, in an upcoming May ... to Manage Specialty Drugs to Reduce Costs and Ensure ... main driver for rising prescription drug costs, which are ...
(Date:5/21/2013)... May 21, 2013 While North Carolina ... with comprehensive travel guides. Brunswick Plantation & Golf Resort ... that include access to 27 holes of "Top10" championship ... in North Carolina, knowing the Top 10 ... takes away the overwhelming task of selecting the course ...
Breaking Medicine News(10 mins):Health News:Research at the cutting edge of knowledge 2Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 2Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 3Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 4Health News:Zane Benefits Publishes New Information on HRA, HSA and FSA Accounts 2Health News:Zane Benefits Publishes New Information on HRA, HSA and FSA Accounts 3Health News:Consulting Firm Execs to Discuss Strategies for Effective Management of Specialty Drugs in AIS’s May 30 Webinar 2Health News:Brunswick Plantation & Golf Resort Named in Top 10 Golf Resorts in North Carolina 2[0] Research at the cutting edge of knowledge[0] Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial[0] Zane Benefits Publishes New Information on HRA, HSA and FSA Accounts[0] Consulting Firm Execs to Discuss Strategies for Effective Management of Specialty Drugs in AIS’s May 30 Webinar[0] Brunswick Plantation & Golf Resort Named in Top 10 Golf Resorts in North Carolina
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |